Skip to main content English


Ulla Klaiber
Priv.-Doz. Dr. med. Ulla Klaiber, M.Sc.

Department of General Surgery (Division of Visceral Surgery)
Position: Consultant

ORCID: 0000-0002-9287-1174


Pancreatectomy; Pancreatic Cancer; Pancreatic Diseases

Research group(s)

Selected publications

  1. Hackert, T.*, Klaiber, U.* et al. (2023) ‘Portal Vein Resection in Pancreatic Cancer Surgery: Risk of Thrombosis and Radicality Determine Survival’, Annals of Surgery, 277(6), pp. e1291–e1298. Available at: *Contributed equall.
  2. Hank, T.*, Klaiber U.* et al. (2023) ‘Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic Cancer’, Annals of Surgery, 277(5), pp. e1089–e1098. Available at: *Contributed equall.
  3. Klaiber, U. et al. (2021) ‘Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer’, Annals of Surgery, 273(1), pp. 154–162. Available at:
  4. Klaiber, U. et al. (2020) ‘Randomized Trial of Pylorus-Preserving vs. Pylorus-Resecting Pancreatoduodenectomy: Long-Term Morbidity and Quality of Life’, Journal of Gastrointestinal Surgery, 24(2), pp. 341–352. Available at:
  5. van Roessel, S. et al. (2020) ‘Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment’, JAMA Oncology, 6(11), p. 1733. Available at: